Novartis Heart Drug Serelaxin Fails In Last Stage Clinical Trial Novartis has announced that its acute heart failure drug serelaxin failed to clear the last stage clinical trials. Following this announcement, Novartis shares dropped by 2.2 percent. by Steve Bowman
Healthy Living/Wellness Necropsy Reveals Beluga Whale At Georgia Aquarium Died Of Heart Failure by Katherine Derla
Xi Jinping Warns Against Chip Restrictions During Talks with Dutch PM Rutte: 'No Force Can Stop China's Progress'
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband